Should the government require companies to list prescription drug prices in their TV ads?

Awaiting Vote
Bill Summary

H.R. 7970 wants to require advertisements for prescription drugs and biological products to include truthful information about their pricing in television ads. To do this, the Secretary of Health and Human Services would demand a statement indicating the price during a televised advertisement for the prescription drug to ensure transparency for all Americans. The Secretary will also be allowed to determine what kinds of regulations apply to the ads, including the format of the statement, if this law applies to other forms of advertisement, and the enforcement mechanisms to ensure companies follow the law. Sponsor: Rep. Nikema Williams (Democrat, Georgia, District 5)
View full bill text ➔

How do you feel?

One click sends your opinion

Opponents say

•    At the time of research and publication, no official opposing statements have been identified.  This does not mean that nobody opposes the bill, nor does it mean that opposing statements will not be made in the future.

Proponents say

•    "Quality, affordable healthcare must include transparent prescription pricing. Constituents have shared horrific stories of rationing prescriptions or struggling to put food on the table just to keep up with skyrocketing medication costs. It’s time to hold Big Pharma accountable for their actions in pursuit of excessive profits. The Plain Prescription Prices Act will lower the cost of prescription drugs for everyone and put power on the side of consumers, so they can make the best choices for their healthcare." Source: Rep. Nikema Williams (Democrat, Georgia, District 5)


•    "Making prescription drug prices more affordable must be a top priority, and citizens should know exactly how much their medication is going to cost…I'm glad to join my House colleagues in this bipartisan effort to ensure the list price is clearly labeled—no gimmicks, no broken promises." Source: Don Bacon (Republican, Nebraska, District 2)